Implanet S.A. (EPA:ALIMP)
0.2400
-0.0010 (-0.41%)
At close: Nov 10, 2025
Implanet Market Cap
Implanet has a market cap or net worth of €30.27 million as of November 10, 2025. Its market cap has increased by 94.55% in one year.
Market Cap
30.27M
Enterprise Value
35.89M
Revenue
11.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.24
Market Cap Chart
Since November 25, 2013, Implanet's market cap has decreased from 107.08M to 30.27M, a decrease of -71.73%. That is a compound annual growth rate of -10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 30.27M | 112.47% |
| Dec 31, 2024 | 14.25M | 442.72% |
| Dec 29, 2023 | 2.62M | -47.64% |
| Dec 30, 2022 | 5.01M | 23.77% |
| Dec 31, 2021 | 4.05M | -24.18% |
| Dec 31, 2020 | 5.34M | 16.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.22B |
| Sanofi | 103.96B |
| Sartorius Stedim Biotech | 18.34B |
| bioMérieux | 12.59B |
| Eurofins Scientific SE | 10.34B |
| Ipsen | 10.18B |
| ABIVAX Société Anonyme | 6.68B |
| Virbac | 2.89B |